Individual plasma concentration–time curves of artemisinin in 15
4.6 (143) · $ 22.50 · In stock
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of the
Comparison of phenobarbital plasma level-to-dose ratios on different
Michael ASHTON, Professor (Full), PhD, University of Gothenburg, Göteborg, GU, Pharmacokinetics and Drug Metabolism Unit (PKDM)
Plasma concentration-time curves for artemiside 5 (solid line) and
PHARMACOKINETICS I-III
Michael ASHTON, Professor (Full), PhD, University of Gothenburg, Göteborg, GU, Pharmacokinetics and Drug Metabolism Unit (PKDM)
Warunee HANPITHAKPONG, Senior Scientist, Ph.D, Mahidol Oxford Tropical Medicine Research Unit (MORU), Bangkok, Department of Pharmacology
Dung NGUYEN Research profile
Real-life effectiveness of anti-malarial treatment regimens: what
Flow chart of patients included in the study. ICU = intensive care
Artemisinin and Derivatives Pathway, Pharmacokinetics
Michael ASHTON, Professor (Full), PhD, University of Gothenburg, Göteborg, GU, Pharmacokinetics and Drug Metabolism Unit (PKDM)
ROC curve analysis of three statistically significant predictors of
